Published in Br J Pharmacol on September 01, 2010
Opioid-induced hypernociception is associated with hyperexcitability and altered tetrodotoxin-resistant Na+ channel function of dorsal root ganglia. Am J Physiol Cell Physiol (2011) 0.84
Molecular Pharmacology of δ-Opioid Receptors. Pharmacol Rev (2016) 0.80
Intrathecal PKA-selective siRNA treatment blocks sustained morphine-mediated pain sensitization and antinociceptive tolerance in rats. J Neurosci Methods (2011) 0.80
The regulation of sGC on the rat model of neuropathic pain is mediated by 5-HT1ARs and NO/cGMP pathway. Am J Transl Res (2016) 0.77
Intrathecal delivery of farnesyl thiosalicylic acid and GW 5074 attenuates hyperalgesia and allodynia in chronic constriction injury-induced neuropathic pain in rats. Neurol Sci (2012) 0.76
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain. Yale J Biol Med (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
Guide to Receptors and Channels (GRAC), 4th Edition. Br J Pharmacol (2009) 8.07
Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol (1980) 6.82
Chronic catheterization of the spinal subarachnoid space. Physiol Behav (1976) 6.16
The complexity of Raf-1 regulation. Curr Opin Cell Biol (1997) 3.25
Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci U S A (1975) 2.71
Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain (1995) 2.41
Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther (2002) 2.32
Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci (2001) 1.76
Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci (2000) 1.71
Opiate-dependent modulation of adenylate cyclase. Proc Natl Acad Sci U S A (1977) 1.60
Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci (2002) 1.58
Peripheral mechanisms of pain and analgesia. Brain Res Rev (2008) 1.55
Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology (1997) 1.55
An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons. Mol Pain (2005) 1.49
Agonist-selective signaling is determined by the receptor location within the membrane domains. Proc Natl Acad Sci U S A (2008) 1.36
Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci (2001) 1.30
ERK and beyond: insights from B-Raf and Raf-1 conditional knockouts. Cell Cycle (2006) 1.24
Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons. Neuroscience (2000) 1.21
Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem (1997) 1.21
Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization. Mol Pharmacol (2006) 1.21
Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neurosci Lett (2005) 1.13
Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br J Pharmacol (2000) 1.12
Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment. J Pharmacol Exp Ther (2003) 1.08
A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia. J Neurosci (1996) 1.07
Peripheral morphine analgesia: synergy with central sites and a target of morphine tolerance. J Pharmacol Exp Ther (1996) 1.07
Clinical experience of long-term treatment with epidural and intrathecal opioids--a nationwide survey. Acta Anaesthesiol Scand (1988) 1.04
The spinal basis of opioid tolerance and physical dependence: Involvement of calcitonin gene-related peptide, substance P, and arachidonic acid-derived metabolites. Peptides (2005) 1.03
Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner. Eur J Pharmacol (2008) 1.01
Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80. J Pharmacol Exp Ther (1996) 0.94
Prostaglandin-induced neuropeptide release from spinal cord. Prog Brain Res (1995) 0.93
Chronic morphine-mediated adenylyl cyclase superactivation is attenuated by the Raf-1 inhibitor, GW5074. Eur J Pharmacol (2006) 0.90
Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase. Biochemistry (2001) 0.90
Expression of alpha-transducin in Chinese hamster ovary cells stably transfected with the human delta-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation. Mol Pharmacol (2001) 0.85
Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatment. Life Sci (2003) 0.84
Down-regulation of c-Cbl by morphine accounts for persistent ERK1/2 signaling in delta-opioid receptor-expressing HEK293 cells. J Biol Chem (2009) 0.84
Sustained morphine treatment augments capsaicin-evoked calcitonin gene-related peptide release from primary sensory neurons in a protein kinase A- and Raf-1-dependent manner. J Pharmacol Exp Ther (2009) 0.83
Phosphorylation of adenylyl cyclase VI upon chronic delta-opioid receptor stimulation. Eur J Pharmacol (1999) 0.83
Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesia. Eur J Pharmacol (2008) 0.80
Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of G(i/o)-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation. Mol Pharmacol (2000) 0.78
The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J (2001) 7.97
A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature (2001) 7.35
Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron (1996) 5.30
Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports. Nucleic Acids Res (1994) 4.77
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem (1993) 3.52
Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis (2000) 3.46
HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med (1999) 3.01
Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci U S A (1993) 2.79
Cadmium and iron transport by members of a plant metal transporter family in Arabidopsis with homology to Nramp genes. Proc Natl Acad Sci U S A (2000) 2.70
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer (2009) 2.39
The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat Genet (1999) 2.32
Stoichiometry of a recombinant GABAA receptor. J Neurosci (1996) 2.23
Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med (1998) 2.20
Quantitative trait loci for refractoriness of Anopheles gambiae to Plasmodium cynomolgi B. Science (1997) 2.08
A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis (2001) 2.07
Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci U S A (1997) 2.03
Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci (2001) 1.95
Distinct potassium channels on pain-sensing neurons. Proc Natl Acad Sci U S A (2001) 1.90
Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res (1999) 1.88
SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. Eur J Pharmacol (1997) 1.83
Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J Pharmacol Exp Ther (2006) 1.75
Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci (2001) 1.72
Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci (2001) 1.67
Protein ladder sequencing. Science (1993) 1.66
A protein from human placental nuclei binds preferentially to 5-methylcytosine-rich DNA. Nature (1984) 1.61
Identification of receptors for neuromedin U and its role in feeding. Nature (2000) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther (2010) 1.59
Critical role of c-Kit in beta cell function: increased insulin secretion and protection against diabetes in a mouse model. Diabetologia (2012) 1.58
Transcription factor expression in the developing human fetal endocrine pancreas. Diabetologia (2008) 1.57
Noninvasive evaluation of ventricular hypertrophy in professional athletes. Circulation (1976) 1.56
Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia. Nat Neurosci (1999) 1.53
Regulation of Rad51 function by c-Abl in response to DNA damage. J Biol Chem (1998) 1.53
Biological monitoring of dichloropropene: air concentrations, urinary metabolite, and renal enzyme excretion. Arch Environ Health (1989) 1.50
Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein. Proc Natl Acad Sci U S A (1999) 1.46
Cigarettes and alcohol in relation to colorectal cancer: the Singapore Chinese Health Study. Br J Cancer (2007) 1.46
Interactions between heterologous FtsA and FtsZ proteins at the FtsZ ring. J Bacteriol (1997) 1.45
Cell loss in isolated human islets occurs by apoptosis. Pancreas (2000) 1.45
Fas-mediated cell death promoted by opioids. Nature (1999) 1.45
The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats. Life Sci (1982) 1.43
Generation and regulation of beta-amyloid peptide variants by neurons. J Neurochem (1998) 1.43
The Arabidopsis dual-affinity nitrate transporter gene AtNRT1.1 (CHL1) is activated and functions in nascent organ development during vegetative and reproductive growth. Plant Cell (2001) 1.43
Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry (1993) 1.42
Suppression of a P450 hydroxylase gene in plant trichome glands enhances natural-product-based aphid resistance. Nat Biotechnol (2001) 1.42
Cell-free assays for gamma-secretase activity. FASEB J (2000) 1.41
Family-based intervention for schizophrenic patients in China. A randomised controlled trial. Br J Psychiatry (1994) 1.41
Isolation of an ftsZ homolog from the archaebacterium Halobacterium salinarium: implications for the evolution of FtsZ and tubulin. J Bacteriol (1996) 1.40
Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry (1999) 1.40
Recalculation of the temperature inside capillaries using high buffer concentrations. J Chromatogr A (2001) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Long-term evaluation of composite sequential bypass for limb-threatening ischemia. J Vasc Surg (1992) 1.39
The interaction of [3H]nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats. Biochem Biophys Res Commun (1982) 1.38
Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol Dis (1999) 1.38
Glial cell line-derived neurotrophic factor normalizes neurochemical changes in injured dorsal root ganglion neurons and prevents the expression of experimental neuropathic pain. Neuroscience (2003) 1.35
Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Radic Biol Med (1999) 1.35
PTEN mutations are uncommon in Proteus syndrome. J Med Genet (2001) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Molecular biology and pharmacology of cloned opioid receptors. FASEB J (1995) 1.34
Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine (2000) 1.34
Identification of the gene (lgtG) encoding the lipooligosaccharide beta chain synthesizing glucosyl transferase from Neisseria gonorrhoeae. Proc Natl Acad Sci U S A (1998) 1.33
Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur J Immunol (1993) 1.33
The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol Rev (1999) 1.33
Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun (1999) 1.32
Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum Mol Genet (2000) 1.30
Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance. Br J Pharmacol (2010) 1.30
Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J Immunol (1995) 1.29
Opioid receptor types and subtypes: the delta receptor as a model. Annu Rev Pharmacol Toxicol (1996) 1.28
Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization. J Biol Chem (1978) 1.28
Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls. Neuroimage (2010) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Gene expression patterns during intramuscular fat development in cattle. J Anim Sci (2008) 1.27
Neuropathic pain: the paradox of dynorphin. Mol Interv (2001) 1.27
Application of cereals and cereal components in functional foods: a review. Int J Food Microbiol (2002) 1.26
Identification and cloning of an orphan G protein-coupled receptor of the glycoprotein hormone receptor subfamily. Biochem Biophys Res Commun (1998) 1.26
AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain. Eur J Pharmacol (1997) 1.25
The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets. Anesthesiology (2001) 1.24
gamma-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid beta peptides of varying length. J Biol Chem (1999) 1.24
Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain. Life Sci (2003) 1.24
Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas. Diabetologia (2011) 1.23
Presenilin 1 regulates pharmacologically distinct gamma -secretase activities. Implications for the role of presenilin in gamma -secretase cleavage. J Biol Chem (2000) 1.22
Hormonal regulation of myosin heavy chain and alpha-actin gene expression in cultured fetal rat heart myocytes. J Biol Chem (1987) 1.22
Structural homology between the Rap30 DNA-binding domain and linker histone H5: implications for preinitiation complex assembly. Proc Natl Acad Sci U S A (1998) 1.21
FMRFamide-related neuropeptides are agonists of the orphan G-protein-coupled receptor GPR54. Biochem Biophys Res Commun (2001) 1.20
Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem (2001) 1.20
Highly spin-polarized room-temperature tunnel injector for semiconductor spintronics using MgO(100). Phys Rev Lett (2005) 1.20
Purple urine bag syndrome in a hemodialysis patient. Kidney Int (2007) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Hepatitis B control in China: knowledge and practices among village doctors. Am J Public Health (1993) 1.19
Risks of lung cancer, chronic bronchitis, ischaemic heart disease, and stroke in relation to type of cigarette smoked. J Epidemiol Community Health (1985) 1.19
Brain viral burden in HIV infection. J Neuropathol Exp Neurol (1994) 1.18
Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain (1997) 1.18
Expression of voltage-dependent K(+) channel genes in mesenteric artery smooth muscle cells. Am J Physiol (1999) 1.18
Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas. Diabetologia (2009) 1.17
The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol (1987) 1.17
A hybrid human and machine resource curation pipeline for the Neuroscience Information Framework. Database (Oxford) (2012) 1.16
Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease. Hum Mol Genet (2000) 1.15
Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. J Immunol (1998) 1.15